Frailty: Prevalence and Response to Left Ventricular Assist Device Therapy in Older Heart Failure Patients

NCT02156583 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2018-04-10

No results posted yet for this study

Summary

This is an observational study evaluating changes in frailty and associated impairments in older heart failure patients receiving left ventricular assist device therapy.

Conditions

  • Systolic Heart Failure

Sponsors & Collaborators

  • Thoratec Corporation

    collaborator INDUSTRY
  • National Skeletal Muscle Research Center

    collaborator UNKNOWN
  • Greater New York Geriatric Cardiology Consortium

    collaborator UNKNOWN
  • Thomas Jefferson University

    lead OTHER

Principal Investigators

  • Gordon R Reeves, MD, MPT · Thomas Jefferson University

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2017-07-31
Completion
2017-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02156583 on ClinicalTrials.gov